₹ 1,047.10
17.15 (1.67%)
A
Alembic Pharmaceuticals
₹ 1,047.10
Alembic Pharmaceuticals EPS Summary (consolidated)
The latest quarterly EPS of Alembic Pharmaceuticals as of Q2 Sep 2026 stands at ₹17.05. This is a 93.75% growth quarter on quarter and 81.38% growth same quarter last year. The forecasted EPS for Q2 Sep 2026 was ₹9.83. It beat the estimate by ₹7.22. For the FY2026 the EPS of Alembic Pharmaceuticals stands at ₹34.33. This is a 15.67% growth compared with FY2025.
Alembic Pharmaceuticals EPS
EPS by Peers

S
Sun Pharmaceutical

D
Divis Laboratories

T
Torrent Pharmaceuticals

L
Laurus Labs

Z
Zydus Life Science
*Based on consolidated figures.

Pay Zero Brokerage on Delivery
Open FREE Demat Account
+91
Or Scan the QR Code to download the Dhan App

